Back
Citius Pharmaceuticals, Inc. Stock Price Chart
Before There's a Price, There's a Position: NatGold Pre-Market
Secure your position now-before access is controlled by price.
Sell
14
CTXR
Citius Pharmaceuticals, Inc.
Last Price:
$0.78
Seasonality Move:
-3.13%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Is Going Digital-And NatGold May Come After Bitcoin
Reserve NatGold Tokens pre-market-no payment required today.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTXR is experiencing slight buying pressure.
Citius Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.8 | Sell |
| 20-day SMA: | 0.85 | Sell |
| 50-day SMA: | 0.99 | Sell |
| 200-day SMA: | 1.16 | Sell |
| 8-day EMA: | 0.4 | Buy |
| 20-day EMA: | 0.2 | Buy |
| 50-day EMA: | 0.09 | Buy |
| 200-day EMA: | 0.02 | Buy |
Citius Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 36.11 | Sell |
| Chaikin Money Flow: | 230836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.78 - 0.9) | Sell |
| Bollinger Bands (100): | (0.91 - 1.41) | Sell |
Citius Pharmaceuticals, Inc. Technical Analysis
| Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals, Inc. Stock
Is Citius Pharmaceuticals, Inc. Stock a Buy?
-
Citius Pharmaceuticals, Inc. share price is 0.76 while CTXR 8-day simple moving average is 0.80, which is a Sell signal.
-
The stock price of CTXR is 0.76 while Citius Pharmaceuticals, Inc. 20-day SMA is 0.85, which makes it a Sell.
-
Citius Pharmaceuticals, Inc. 50-day simple moving average is 0.99 while CTXR share price is 0.76, making it a Sell technically.
-
CTXR stock price is 0.76 and Citius Pharmaceuticals, Inc. 200-day simple moving average is 1.16, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
14
Citius Pharmaceuticals, Inc. (CTXR)
is a Sell
Is Citius Pharmaceuticals, Inc. a Buy or a Sell?
-
Citius Pharmaceuticals, Inc. stock is rated a SellThe current Citius Pharmaceuticals, Inc. [CTXR] share price is $0.76. The Score for CTXR is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals, Inc. Stock Info
Market Cap:
15.8M
Price in USD:
0.76
Share Volume:
404.5K
Citius Pharmaceuticals, Inc. 52-Week Range
52-Week High:
2.97
52-Week Low:
0.63
Sell
14
Citius Pharmaceuticals, Inc. (CTXR)
is a Sell
Citius Pharmaceuticals, Inc. Share Price Forecast
-
What is the Citius Pharmaceuticals, Inc. stock price today?The Citius Pharmaceuticals, Inc. stock price is 0.76 USD today.
-
Will CTXR stock go up or go down?Citius Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals, Inc. is overvalued.
Is Citius Pharmaceuticals, Inc. Stock a Buy?
-
Citius Pharmaceuticals, Inc. share price is 0.76 while CTXR 8-day exponential moving average is 0.40, which is a Buy signal.
-
The stock price of CTXR is 0.76 while Citius Pharmaceuticals, Inc. 20-day EMA is 0.20, which makes it a Buy.
-
Citius Pharmaceuticals, Inc. 50-day exponential moving average is 0.09 while CTXR share price is 0.76, making it a Buy technically.
-
CTXR stock price is 0.76 and Citius Pharmaceuticals, Inc. 200-day simple moving average is 0.02, creating a Buy signal.
Fundamental Analysis of Citius Pharmaceuticals, Inc.
Is Citius Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.98 per share, and an increase next year of $1.20 per share.
Technical Analysis of Citius Pharmaceuticals, Inc.
Should I short Citius Pharmaceuticals, Inc. stock?
-
CTXR Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Citius Pharmaceuticals, Inc. is a Buy
-
Citius Pharmaceuticals, Inc. Relative Strength Index (RSI) is 36.11, which suggest Citius Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Citius Pharmaceuticals, Inc. is (0.78 - 0.9), which suggest Citius Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for Citius Pharmaceuticals, Inc. is (0.91 - 1.41), which suggest Citius Pharmaceuticals, Inc. is a Sell
* Citius Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.